Daily Stock Analysis, ACUR, Acura Pharmaceuticals Inc, priceseries

Acura Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
0.55
Close
0.52
High
0.55
Low
0.50
Previous Close
0.55
Daily Price Gain
-0.03
YTD High
1.40
YTD High Date
Feb 13, 2017
YTD Low
0.46
YTD Low Date
Mar 6, 2017
YTD Price Change
-0.32
YTD Gain
-38.10%
52 Week High
3.52
52 Week High Date
Apr 19, 2016
52 Week Low
0.46
52 Week Low Date
Mar 6, 2017
52 Week Price Change
-1.58
52 Week Gain
-75.24%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 12. 2015
2.70
Mar 4. 2015
3.50
13 Trading Days
29.65%
Link
LONG
Mar 25. 2015
3.65
Apr 8. 2015
3.92
9 Trading Days
7.39%
Link
LONG
Mar 18. 2016
2.15
Apr 12. 2016
2.75
16 Trading Days
28.07%
Link
LONG
Apr 13. 2016
2.96
Apr 28. 2016
3.21
11 Trading Days
8.53%
Link
LONG
Sep 22. 2016
1.67
Sep 23. 2016
1.77
1 Trading Days
5.99%
Link
Company Information
Stock Symbol
ACUR
Exchange
NasdaqCM
Company URL
http://www.acurapharm.com
Company Phone
847-705-7709
CEO
Robert B. Jones
Headquarters
Illinois
Business Address
616 N. NORTH COURT, SUITE 120, PALATINE, IL 60067
Sector
Equity
Industry Category
Drugs
Industry Group
Drug Delivery
CIK
0000786947
About

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, researches, develops, and commercializes products to address medication abuse and misuse.

Description

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, researches, develops, and commercializes products to address medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; Egalet Ltd.; and Egalet Corporation to manufacture and commercialize Oxaydo products worldwide. The company was founded in 1935 and is based in Palatine, Illinois.